Otsuka Pharmaceutical announced that the FDA is reviewing investigational centanafadine -- a potential first-in-class ...
Back in the 1960s, when Ritalin (methylphenidate) was first approved by the US Food and Drug Administration (FDA) for treating behavioural problems, parents and teachers alike were impressed by the ...
The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...
For families in the UK, the message from our research is an important one. TNS appears to be safe, but safety alone is not ...
This article was reviewed by Lynn Marie Morski, MD, JD. For women with attention-deficit/hyperactivity disorder (ADHD), menopause can bring a whole new set of ...
A Virginia Tech study could strike a new chord in the world of treatment for attention deficit hyperactivity disorder or ADHD ...
Yahoo Sports Daily hosts Caroline Fenton and Jason Fitz are joined by NFL insider with Fox Sports Jay Glazer on behalf of ...
While proven a safe method, external trigeminal nerve stimulation was nonsuperior to sham treatment as early as 4 weeks and as long as 6 months in children and adolescents with ADHD, according to data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results